| Product Code: ETC6747963 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Morphine Drugs Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Morphine Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 China Morphine Drugs Market - Industry Life Cycle |
3.4 China Morphine Drugs Market - Porter's Five Forces |
3.5 China Morphine Drugs Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 China Morphine Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Morphine Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring pain management |
4.2.2 Growing aging population in China |
4.2.3 Rising awareness about pain management and palliative care |
4.3 Market Restraints |
4.3.1 Stringent regulations and restrictions on opioid drugs |
4.3.2 Limited availability and accessibility of morphine drugs in rural areas |
4.3.3 Stigma and misconceptions associated with opioid use |
5 China Morphine Drugs Market Trends |
6 China Morphine Drugs Market, By Types |
6.1 China Morphine Drugs Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 China Morphine Drugs Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 China Morphine Drugs Market Revenues & Volume, By Immediate Release/ Short Acting Opioids, 2021- 2031F |
6.1.4 China Morphine Drugs Market Revenues & Volume, By Codeine, 2021- 2031F |
6.1.5 China Morphine Drugs Market Revenues & Volume, By Oxycodone, 2021- 2031F |
6.1.6 China Morphine Drugs Market Revenues & Volume, By Hydrocodone, 2021- 2031F |
6.1.7 China Morphine Drugs Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.1.8 China Morphine Drugs Market Revenues & Volume, By Morphine, 2021- 2031F |
6.1.9 China Morphine Drugs Market Revenues & Volume, By Extended Release/Long Acting Opioids, 2021- 2031F |
6.1.10 China Morphine Drugs Market Revenues & Volume, By Extended Release/Long Acting Opioids, 2021- 2031F |
6.2 China Morphine Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Morphine Drugs Market Revenues & Volume, By Pain Relief, 2021- 2031F |
6.2.3 China Morphine Drugs Market Revenues & Volume, By Anesthesia, 2021- 2031F |
6.2.4 China Morphine Drugs Market Revenues & Volume, By Cough Suppression, 2021- 2031F |
6.2.5 China Morphine Drugs Market Revenues & Volume, By Diarrhoea Suppression, 2021- 2031F |
6.2.6 China Morphine Drugs Market Revenues & Volume, By De-addiction, 2021- 2031F |
7 China Morphine Drugs Market Import-Export Trade Statistics |
7.1 China Morphine Drugs Market Export to Major Countries |
7.2 China Morphine Drugs Market Imports from Major Countries |
8 China Morphine Drugs Market Key Performance Indicators |
8.1 Number of healthcare facilities offering palliative care services |
8.2 Percentage of healthcare professionals trained in pain management |
8.3 Rate of opioid prescriptions for pain management |
9 China Morphine Drugs Market - Opportunity Assessment |
9.1 China Morphine Drugs Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 China Morphine Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Morphine Drugs Market - Competitive Landscape |
10.1 China Morphine Drugs Market Revenue Share, By Companies, 2024 |
10.2 China Morphine Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here